nifty-50

NIFTY 50

up

0.00

+0.00

nifty-50

GIFT NIFTY

up

0.00

+0.00

Background Grid Hero
Background Pattern Hero
Background Grid Hero
Background Pattern Hero
NSE Symbol: MARKSANS
Sector: NA
Industry: NA
Marksans Pharma Limited
0.00

Today's Low

0.00

Today's High

0.00

52 Week Low

0.00

52 Week High

0.00

image Fundamentals Analysis

Market Cap 0 Cr
Book Value 0.00
PE Ratio 0.00
PE for Sector 0.00
ROE 0.00 %
Dividend Yield 0.00 %
Open 0.00
52 Week High 0.00
52 Week Low 0.00
PB Ratio 0.00
ROCE 0.00 %
EPS 0.00

image About Company

image Quarterly Results

Consolidated Figures in Rs. Crores

Disclaimer

image Stock News - Marksans Pharma Limited [MARKSANS]

Quick Lookup
1W 0.00%
1M 0.00%
3M 0.00%
6M 0.00%
9M 0.00%
1Y 0.00%
Technical
RSI (14) 0.00
MACD (12,26) 0.00
Simple Moving Avg
5-SMA 0.00
10-SMA 0.00
20-SMA 0.00
50-SMA 0.00
100-SMA 0.00
200-SMA 0.00
Exponential Avg
50-EMA 0.00
100-EMA 0.00
200-EMA 0.00
Shareholding
shareholding-pattern
Promotors 0.00%
Public 0.00%
DII 0.00%
FII 0.00%

✨ Trendlyne Indicators ✨


Marksans Pharma Ltd.
Strengths right arrow 16 S
Weakness right arrow 1 W
Opportunity right arrow 4 O
Threats right arrow 1 T
What is SWOT Analysis ?
Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Strong Momentum: Price above short, medium and long term moving averages
  • Consistent Highest Return Stocks over Five Years
  • Relative Outperformance versus Industry over 1 Month
  • Relative Outperformance versus Industry over 1 Year
  • PEG lower than Industry PEG
  • Stocks gaining versus previous close, open price and RSI
  • Relative Outperformance versus Industry over 1 Week
  • Relative Outperformance versus Industry over 1 Month
  • Overbought by Money Flow Index (MFI)
  • Companies with Low Debt
  • Increasing Revenue every Quarter for the past 4 Quarters
  • Companies with Zero Promoter Pledge
  • Highest Recovery from 52 Week Low
  • RSI indicating price strength
  • Top Gainers
  • Stocks Outperforming their Industry Price Change in the Quarter
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Highest FII stock holdings
  • FII / FPI or Institutions increasing their shareholding
  • MFs increased their shareholding last quarter
  • Mutual Funds Increased Shareholding over the Past Two Months
  • US FDA Warning Letter
Trendlyne